AZ Delta Campus Wilgenstraat

Roeselare, West-Vlaanderen 8800

0 studies enrolling now · 3 studies all time

What they study most

NASH - Nonalcoholic Steatohepatitis, Overactive Bladder, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed